Sagital Pharmaceutical Private Limited
About Sagital Pharmaceutical Private Limited
Data last updated:
Sagital Pharmaceutical Private Limited is a private limited company based in Etah, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 July 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24232UP2004PTC028833. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.75 Lakh. It is led by directors including Praja Palan (Managing Director) and Sudhir Kumar Verma.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 11/3 Ist Floor Neelam Market, Etah, Uttar Pradesh, India.
As per the financials filed for FY 2022, the company reported a revenue of ₹43,680, a growth of 2% compared to the previous year. For the same year it recorded a net loss of ₹354 (net margin -0.8%) and EBITDA of -₹354 (EBITDA margin -0.8%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sagital Pharmaceutical Private Limited's registered office is in Etah, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address11/3 Ist Floor Neelam Market, Etah, Uttar Pradesh, India
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sagital Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sagital Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sagital Pharmaceutical Private Limited, buy the company report.
Financials of Sagital Pharmaceutical Private Limited
FY 2023 filings availableSagital Pharmaceutical Private Limited reported revenue of ₹43,680 (up 2% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 2% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 12%. EBITDA fell 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹354 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹354 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.8% | ||||
| Net Profit Margin | -0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sagital Pharmaceutical Private Limited, buy the company report.
Board of directors of Sagital Pharmaceutical Private Limited
Sagital Pharmaceutical has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Praja Palan | Managing Director | 07 Jul 2004 | 22 Years 3 Months | Current |
| Sudhir Kumar Verma | Director | 07 Jul 2004 | 22 Years 3 Months | Current |
| Manoj Sabharwal | Director | 07 Jul 2004 | 22 Years 3 Months | Current |
| Sandeep Rajput | Director | 07 Jul 2004 | 22 Years 3 Months | Current |
| Vipin Kumar | Director | 07 Jul 2004 | 22 Years 3 Months | Current |
Peer comparison
Sagital Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aleomed Lifesciences India Private Limited | ₹45,550 (FY 2022) | Ahmedabad, Gujarat, India | ||||
| Activebio Pharmaceuticals Private Limited | ₹45,000 (FY 2017) | New Delhi, Delhi, India | ||||
| Getwell Chemicals Private Limited | ₹44,378 (FY 2025) | -100.0% | Raipur, Chhattisgarh, India | |||
| Swain Life Sciences Private Limited | ₹44,286 (FY 2021) | -89.0% | Sultanpur, Uttar Pradesh, India | |||
| Meliora Therapeutics Private Limited | ₹43,986 (FY 2025) | -80.0% | Hyderabad, Telangana, India | |||
| Sagital Pharmaceutical Private Limitedthis company | ₹43,680 (FY 2022) | -₹354 | -0.8% | 2.0% | Etah, Uttar Pradesh, India | |
| Velcare Products Private Limited | ₹43,480 (FY 2024) | 16.0% | Chennai, Tamil Nadu, India | |||
| Carocure Discovery Solutions Private Limited | ₹43,251 (FY 2021) | -46.0% | Begumpet, Hyderabad, Telangana, India | |||
| Neutro Lifesciences Private Limited | ₹43,040 (FY 2024) | -64.0% | Pune, Maharashtra, India | |||
| Aaeonpro Herbals Private Limited | ₹42,952 (FY 2020) | Cheeka, Haryana, India | ||||
| DBS Pharma Private Limited | ₹42,900 (FY 2024) | -100.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Sagital Pharmaceutical Private Limited, buy the company report.
Auditor
Sagital Pharmaceutical Private Limited is audited by A.K.A & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A.K.A & CO. | FY 2017 | 089154 |
Shareholding
The shareholding of Sagital Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sagital Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sagital Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sagital Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sagital Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Sagital Pharmaceutical Private Limited, buy the company report.
Recent activity
Sagital Pharmaceutical Private Limited has 9 board changes on record since 2004: 7 appointments and 2 cessations. The latest: Shashi Kant ceased to be Director on 26 Sep 2024.
Frequently asked questions
Sagital Pharmaceutical is an active private limited company based in Etah, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 July 2004 (22+ years old) and is registered under CIN U24232UP2004PTC028833.
Sagital Pharmaceutical has 5 current directors:
- Praja Palan - Managing Director
- Sudhir Kumar Verma - Director
- Manoj Sabharwal - Director
- Sandeep Rajput - Director
- Vipin Kumar - Director
The latest financial statements of Sagital Pharmaceutical on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
No. Sagital Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Sagital Pharmaceutical is U24232UP2004PTC028833. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sagital Pharmaceutical was incorporated on 07 July 2004, making it 22+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Sagital Pharmaceutical by revenue are Aleomed Lifesciences India Private Limited, Activebio Pharmaceuticals Private Limited, Getwell Chemicals Private Limited, Swain Life Sciences Private Limited, Meliora Therapeutics Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shashi Kant ceased to be Director on 26 Sep 2024. Lalit Sabharwal ceased to be Director on 21 Dec 2014. Lalit Sabharwal was appointed as Director on 07 Jul 2004. Sagital Pharmaceutical has 9 board changes on record in total.
The registered office of Sagital Pharmaceutical is at 113 Ist Floor Neelam Market, Etah, Uttar Pradesh, India.
Sagital Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Sagital Pharmaceutical is compliant as of 24 September 2026. The company is actively filing with the Registrar of Companies.